Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
L.T. Burgers
Observed names:
L Burgers,
L. Burgers,
L. T. Burgers,
LT Burgers
Institutions:
Pfizer (Netherlands),
Erasmus University Rotterdam
Observed institutions:
Pfizer (Netherlands),
Erasmus University Rotterdam
OpenAlex ID:
A5113561820
A systematic review and economic evaluation of new-generation computed tomography scanners for imaging in coronary artery disease and congenital heart disease: Somatom Definition Flash, Aquilion ONE, Brilliance iCT and Discovery CT750 HD
2013
·
M Westwood
, M Al
, et al.
·
Health Technology Assessment
·
180
PDF
How to prepare a systematic review of economic evaluations for clinical practice guidelines: database selection and search strategy development (part 2/3)
2016
·
FW Thielen
, GAPG Van Mastrigt
, et al.
·
Expert Review of Pharmacoeconomics & Outcomes Research
·
149
PDF
Cost-effectiveness of Elective Endovascular Aneurysm Repair Versus Open Surgical Repair of Abdominal Aortic Aneurysms
2016
·
L.T. Burgers
, A.C. Vahl
, et al.
·
European Journal of Vascular and Endovascular Surgery
·
69
Treatment costs of acute myocardial infarction in the Netherlands
2013
·
R. R. Soekhlal
, L. T. Burgers
, et al.
·
Netherlands Heart Journal
·
61
Is it cost-effective to use a test to decide which individuals with an intermediate cardiovascular disease risk would benefit from statin treatment?
2014
·
L.T. Burgers
, S.T. Nauta
, et al.
·
International Journal of Cardiology
·
12
Cost-effectiveness analysis of new generation coronary CT scanners for difficult-to-image patients
2016
·
L. T. Burgers
, W. K. Redekop
, et al.
·
The European Journal of Health Economics
·
9
Literature search strategies
2011
·
ME Westwood
, M Al
, et al.
·
8
Treatment variation in stent choice in patients with stable or unstable coronary artery disease
2016
·
L. T. Burgers
, E. A. McClellan
, et al.
·
Netherlands Heart Journal
·
5
PDF
Economic Evaluation of Mandibular Advancement Device to Treat Obstructive Sleep Apnea
2013
·
A. Giannopoulou
, L.T. Burgers
, et al.
·
Value in Health
·
2
Cost Analysis of two Aftercare Strategies in Chronic Continuous Intrathecal Baclofen Therapy in Patients with Intractable Spasticity
2014
·
L.T. Burgers
, S.M.E Goslinga-van der Gaag
, et al.
·
Value in Health
·
1
PDF
Cost-Effectiveness Of Disease Management Programs For Cardiovascular Risk And Copd In The Netherlands
2014
·
A. Tsiachristas
, L.T. Burgers
, et al.
·
Value in Health
·
1
PDF
PMD83 Using Five Existing Models to Comprehensively Model the Cost-Effectiveness of A High Definition CT Scanner in A Coronary Artery Disease Population: A Nice Diagnostic Guidance Project
2011
·
L.T. Burgers
, W. Redekop
, et al.
·
Value in Health
·
1
Dalteparin vs. vitamin K antagonist (VKA) for the prevention of recurrent venous thromboembolism (VTE) in cancer patients with renal insufficiency: A patient level pharmacoeconomic analysis in three European countries
2016
·
L. Shane
, G. Dranitsaris
, et al.
·
Annals of Oncology
Cost-effectiveness of open vs endovascular repair of abdominal aortoc aneurysm: a systemic review
2014
·
C.A. Bochove van
, L.T. Burgers
Decision Analytic Models Used in Estimating the Cost-Effectiveness of Drug-Eluting Stents Versus Bare-Metal Stents: A Systematic Review
2013
·
L.T. Burgers
, W.K. Redekop
, et al.
·
Value in Health
Challenges in Modelling the Cost Effectiveness of Interventions in Cardiovascular Disease
2013
·
L.T. Burgers
, W.K. Redekop
, et al.
·
Value in Health
PDF
Study-specific guide to completion of QUADAS-2
2013
·
ME Westwood
, M.Arunmozhi et al.
, et al.
Details of input provided by experts
2013
·
Marie Westwood
, Maiwenn Al
, et al.
The National Institute for Health and Clinical Excellence guidance relevant to treatment of congenital heart disease in childhood
2013
·
Marie Westwood
, M Al
, et al.
CV2 Is It Worth Spending Any Money to Develop a Biomarker Test to Optimize Statin Treatment for Individuals With an Intermediate Cardiovascular Risk?
2012
·
L.T. Burgers
, S.T. Nauta
, et al.
·
Value in Health
PMD81 Decision Analytic Models Used in Estimating the Cost-Effectiveness of Drug-Eluting Stents versus Bare-Metal Stents
2011
·
L.T. Burgers
, W. Redekop
, et al.
·
Value in Health
Pcv94 Potential Cost-effectiveness of a Biomarker Test to Stratify Patients Indicated for a Coronary Stent
2010
·
LT Burgers
, WK Redekop
, et al.
·
Value in Health
PDF
Pcv68 Potential Cost-effectiveness of a Biomarker Test to Reclassify Patients With an Intermediate Risk Based on the Framingham Risk Score Into a Lower or Higher Category to Optimize Statin Therapy
2010
·
LT Burgers
, WK Redekop
, et al.
·
Value in Health
PDF
Show more works
View as search
Works count:
23
Citation count:
498
H-index:
7
I10-index:
5
Year
Topic
Type